New drug combo shows early promise in tough cancers
NCT ID NCT05954871
First seen Nov 17, 2025 · Last updated May 16, 2026 · Updated 18 times
Summary
This early-stage study tested a new drug called GDC-1971 combined with standard treatments for advanced lung or colorectal cancer. The main goal was to check safety and find the right dose in 10 patients. It is a first step to see if this combination might help control these cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Border Medical Oncology
Wodonga, New South Wales, 3690, Australia
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START South Texas Accelerated Research Therapeutics-San Antonio
San Antonio, Texas, 78229, United States
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
St Vincent's Hospital Melbourne
Fitzroy, Victoria, 3065, Australia
Conditions
Explore the condition pages connected to this study.